AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BROMURE DE PRIFINIUM

7 registrations across 3 African markets— 5 active

Markets with BROMURE DE PRIFINIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
FRIDIAL ENFANT 250MG/50ML SOLUTION BUVABLE FLACON DE 50ML🇨🇮Côte d'IvoireFRILAB SAexpiredJun 2026
FRIDIAL 30MG COMPRIME PELLICULE BOITE DE 20🇨🇮Côte d'IvoireFRILAB SAexpiredJan 2026
FRIDIAL
comprimé pelliculé / 30 mg
🇸🇳SenegalFRILAB SAactive
FRIDIAL
comprimé pelliculé / 30 mg
🇸🇳SenegalFRILAB SAactive
FRIDIAL
solution buvable / 250 mg
🇸🇳SenegalFRILAB SAactive
FRIDIAL® 30 CP PELL BTE(1 X 20) FRILAB
comprimé pelliculé, boite d' un
🇲🇬MadagascarFRILAB S.A.active
FRIDIAL® 30 CP PELL BTE(1 X 20) FRILAB
comprimé pelliculé, boite d' un
🇲🇬MadagascarFRILAB S.A.active

BROMURE DE PRIFINIUM in Africa — Regulatory Overview

BROMURE DE PRIFINIUM is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Madagascar. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.